| Literature DB >> 17640330 |
Matthew E Falagas1, Effie A Zarkadoulia, Eleni N Ioannidou, George Peppas, Christos Christodoulou, Petros I Rafailidis.
Abstract
INTRODUCTION: We sought to review the available evidence regarding the effect of psychosocial factors on the survival of breast cancer patients.Entities:
Mesh:
Year: 2007 PMID: 17640330 PMCID: PMC2206717 DOI: 10.1186/bcr1744
Source DB: PubMed Journal: Breast Cancer Res ISSN: 1465-5411 Impact factor: 6.466
Characteristics of studies examining psychosocial factors associated with breast cancer survival
| Reference | Setting | Type of study | Study population | Aim of the study |
| Greer | King's College Hospital, UK | Prospective | 69 women with early breast cancer (T 0–1, N 0–1, M 0) | Examination of the effect of the psychological response to breast cancer on outcome |
| Derogatis | Johns Hopkins Oncology Center, Baltimore, USA | Prospective | 35 women under treatment for metastatic breast cancer | Examination of the effect of psychological factors on breast cancer survival |
| Marshall | Roswell Park Memorial Institute | Cohort analysis | 352 white women with primary breast cancer presenting between 1958 and 1960 | Examination of the effect of the social environment on breast cancer survival |
| Jensen | USA | Prospective | Three groups (G) of women: G1 ( | Examination of the effect of psychological factors on the survival/recurrence |
| Jamison | Adult outpatient Oncology Clinic of Vanderbilt University Hospital, Nashville | Prospective | 49 women with metastatic breast cancer | Examination of the effect of psychosocial factors on breast cancer survival |
| Hislop | A Maxwell Evans Clinic, Vancouver, Canada | Prospective | 133 women with primary ductal breast cancer (stages I to IV) diagnosed between June 1980 and May 1981 | Examination of the effect of psychosocial factors on breast cancer survival/recurrence |
| Cassileth | University of Pennsylvania Cancer Center, USA | Prospective (controlled) | 204 patients with advanced, prognostically poor malignant disease at diagnosis (Group I), and 155 patients with intermediate or high-risk melanoma or stage II breast cancer (Group II); breast cancer patients | Examination of the effect of psychosocial factors on breast cancer survival in an 8 year follow-up period |
| Levy | NIH Clinical Center | Prospective | 36 women with recurrent breast cancer | Examination of the effect of biological and psychological factors on breast cancer survival |
| Ramirez | Guy's hospital, London | Case control | 50 women who had developed a first recurrence after treatment for operable breast cancer, 50 who had operable breast cancer in remission | Examination of the effect of stressful life events on breast cancer recurrence |
| Barraclough | Breast clinics in Southampton and Portsmouth | Prospective | 204 breast cancer patients without clinical evidence of spread beyond the axilla, treated either with mastectomy or wide excision followed by radiotherapy | Examination of the effect of psychosocial factors on breast cancer recurrence |
| Morris | Charing Cross and Royal Marsden Hospitals, London, UK | Prospective | 88 patients with early breast cancer T 0–2, N 0–1, M 0 | Examination of the effect of psychological response to cancer disease on survival/recurrence 3 years post diagnosis and 5 years later |
| Reynolds | National Cancer Institute, Atlanta, Georgia; New Orleans, Louisiana; San Francisco, Oakland, California | Prospective | 552 black and 486 white women with newly diagnosed breast cancer of any stage | Examination of the effect of social factors on breast cancer survival |
| Tross | Multi-centre study, USA | Prospective | 280 women with stage II breast cancer who have undergone surgery and participated in a national clinical trial of CALGB involving 4 adjuvant therapy regimens | Examination of the effect of psychological factors on breast cancer survival/recurrence over a 15 year period |
| Buddeberg | Department of Gynaecology, Zurich and Basel, Switzerland, and Hospital Gynaecology and Obstetrics, Bad Sackingen, Germany | Prospective | 107 women with early breast cancer who had undergone surgery 6 months earlier | Examination of the effect of different coping strategies on breast cancer survival, 5 to 6 years after primary surgical treatment |
| Kreitler | Five hospitals in the centre of Israel | Prospective | 96 women with stage I, II breast cancer | Examination of the effect of psychological factors on breast cancer survival/recurrence |
| Tominaga | Tochigi Cancer Centre hospital, Saitama, Japan | Prospective | 398 female patients who had undergone surgery for primary breast cancer between 1 September 1986 and 31 January 1995 at the Tochigi Cancer Centre Hospital and followed up in the outpatient clinic; some patients were treated with radiation and/or chemotherapy in addition to surgical treatment | Examination of the effect of social factors on breast cancer survival in a follow-up period up to the end of October 1995 or death |
| Brabander and Gerits 1999 [20] | The University Hospital of the Free University of Brussels, Belgium | Prospective | 44 patients with stage I to III primary breast carcinoma (56 women were admitted to the University Hospital of the Free University of Brussels for a breast biopsy and 44 of them had a primary mammary carcinoma) | Examination of the effect of acute and chronic stress on breast cancer recurrence in 3.5 year follow-up period |
| Watson | Royal Marsden Hospital, London and Sutton, UK | Prospective | 578 women with an early stage breast cancer (stages I and II), diagnosed 4 to 12 weeks before the inclusion date; their psychological response was measured 4 to 12 weeks and 12 months after diagnosis | Examination of the effect of psychological factors on breast cancer survival/recurrence in an at least 5 year follow-up period |
| Reynolds | National Cancer Institute, Atlanta, Georgia; New Orleans, Louisiana; San Francisco, Oakland, California | Prospective | 442 black and 405 white women with invasive breast cancer of any stage diagnosed during 1985 to 1986 | Examination of the effect of different coping strategies on breast cancer survival |
| Butow | Department of Medical Oncology, Sydney, Australia | Prospective | 99 patients with metastatic breast cancer seen for the first time between 1991 and 1995 in the Department of Medical Oncology in a major teaching hospital in Sydney. Women entered the study a median of 4.7 months since diagnosis of distant metastases | Examination of the effect of psychosocial factors on breast cancer survival in a 2 year follow-up period |
| Weihs | Four academic medical centres in Washington, USA | Prospective cohort | 32 (out of 65 eligible) patients with recurrent breast cancer diagnosed 6 to 19 months earlier and stabilized using surgical, medical and/or radiation therapies | Examination of the effect of psychological factors on breast cancer survival at 6 and 19 months after diagnosis |
| Graham | NHS Breast Clinic, London; 1991 to 1999 | Prospective observational cohort | Consecutive series of 222 women diagnosed at Guy's Hospital between May 1991 and July 1994, aged 60 and under, newly diagnosed as having a primary operable breast tumour; 202/222 (91%) eligible women participated in the first life experiences interview, while 170 (77%) provided complete interview data either up to 5 years after diagnosis or recurrence | Examination of the effect of stress on breast cancer recurrence in a 5 year follow-up period |
| Soler-Vila | 22 Connecticut hospitals, USA | Prospective cohort | 145 African-American and 177 white women (out of 423 eligible women) diagnosed with a first primary breast cancer of any stage between January 1987 and March 1989 | Examination of the effect of psychosocial factors on all-cause mortality and breast cancer mortality in 10 year follow-up period |
| Soler-Vila | 22 Connecticut hospitals, USA | Prospective | 145 African-American and 177 white women (out of 423 eligible women) diagnosed with a first primary breast cancer between January 1987 and March 1989 | Examination of the effect of cancer-specific beliefs on breast cancer survival in a 15 year follow-up period |
| Hjerl | Denmark | Retrospective | 20,589 women with breast cancer; 10,382 had early stage (tumour size <50 mm and no axillary lymph nodes infiltrated), 10,211 had late stage breast cancer (tumour size >50 mm, at least one infiltrated axillary lymph node, malignancy stage II or III in premenopausal women) | Examination of the effect of depression on breast cancer survival |
| Goodwin | Toronto, Ontario, Canada | Prospective | 397 women diagnosed with breast cancer at participating University of Toronto teaching hospitals between October 1991 and May 1996. The patients were under 75 years of age, with T1 to T3, N0/N1, and M0 breast cancer; they represented women recruited during the final 5 years of a larger prospective cohort study examining prognostic effects of a number of lifestyle-related factors | Examination of the effect of health-related quality of life (HRQOL) and psychosocial factors on breast cancer survival/recurrence 2 months after diagnosis and 1 year later |
| Osborne | Four Melbourne public teaching hospitals; Preston and Northcote Community Hospital, Western Hospital, Maroondah Hospital, Dandenong Hospital | Prospective | 62 women with first primary breast cancer who had no clinically obvious metastatic disease; women had completed chemotherapy treatment more than 4 weeks prior to their entry to the study | Examination of the effect of immune status and psychosocial factors on breast cancer survival in a 6.1 to 7.9 year follow-up period |
| Weihs | Washington, USA | Prospective | 90 (out of the 183 eligible participants) women with invasive breast cancer stages II and III | Examination of the effect of social support on breast cancer survival in an 8 to 9 year follow-up period |
| Osborne | USA (the Surveillance, Epidemiology, and End Results (SEER) tumour registries is supported by the National Cancer Institute and includes registries in selected geographic areas: Detroit, San Francisco/Oakland, Atlanta, Seattle, Los Angeles and San Jose/Monterey, and the States of Connecticut, Iowa, New Mexico, Utah, and Hawaii) | Retrospective | 32,268 women aged 65 years and older who were diagnosed with breast cancer of any stage from 1991 to 1995 and were followed over a 3 year period | Examination of the effect of marital status on breast cancer survival in a 3 year follow-up period |
| Lehto | Tampere University Hospital Oncology Clinic, Finland | Prospective | 101 (out of 102) patients under 72 years of age with localized or regional breast cancer, who were admitted for treatment and/or follow-up to the Tampere University Hospital Oncology Clinic from January to October 1996 | Examination of the effect of psychosocial factors on breast cancer survival |
| Kroenke | USA | Prospective study, based on the Nurses' Health Study (NHS) of 121,700 USA female nurses (at baseline in 1976, and biennially, participants provided health behaviour and medical history information through mailed questionnaires. A subset ( | 2,835 (out of 3,248) women aged 46 to 71 in 1992 from the Nurses' Health Study, who were diagnosed with stages 1 to 4 breast cancer between 1992 and 2002, without previous diagnosed cancer (except non-melanoma skin cancer) and who responded to social networks questions before diagnosis. Also, 1,753 women similarly diagnosed, without prior cancer, who completed social networks questions 1 to 4 years after diagnosis but before recurrence (defined as a second cancer on a routine NHS follow-up if lung, liver, bone, or brain cancer) | Examination of the effect of social factors on breast cancer survival in a 12 year follow-up period |
Methods and outcomes of studies examining the association of psychosocial factors and breast cancer survival
| Reference | Method | Disease outcome | Psychological/psychosocial factors examined | Main findings |
| Greer | Clinical and psychological assessment of patients preoperatively and 3 and 12 months postoperatively and then annually for 4 years. Patients were interviewed and completed psychological tests. Rating scales were devised to measure social adjustment (marital, sexual, interpersonal relationships, work record). Depression was measured by Hamilton rating scale, hostility by Caine and Foulds hostility and direction of hostility questionnaire (HDHQ), extraversion and neuroticism by Eysnack personality inventory (EPI), intelligence by Mill Hill vocabulary scale. At follow up examination, ratings of social adjustment and of depression were repeated and patients' psychological responses to cancer were assessed | At 5 years follow up, 33 patients (49%) were alive and well without signs of recurrence, 16 patients (24%) were alive with metastases, 18 (27%) had died of breast cancer; 2 patients died of disorders other than cancer | Psychological responses: denial, fighting spirit, stoic acceptance, and helplessness/hopelessness. Psychosocial factors: social class, reaction on first discovering the breast lump, delay in seeking advice, reaction to stressful events, expression/suppression of anger, depression, hostility, depressive illness (during 5 previous years), psychological stress, sexual adjustment, interpersonal relationships, work record, extroversion, neuroticism, verbal intelligence | Recurrence-free survival was significantly more common among patients who reacted to cancer with denial or fighting spirit than among patients who responded with stoic acceptance, and helplessness/hopelessness |
| Derogatis | Initial evaluation of the patient at their second visit to outpatient department. Interview and assessment of psychological symptoms using the SCR-90 R, the Affect Balance Scale (ABS), the Global Adjustment to Illness Scale (GAIS), the Patients' Attitude, Information and Expectancy form (PAIE). The treating oncologist also completed GAIS and PAIE 3 days after the visit. Medical data were also recorded | 13 patients lived less than 1 year and were characterized as short-term survivors; 22 patients lived more than 1 year and were characterized as long-term survivors | Joy, contentment, vigour, affection, anxiety, depression, hostility, psychoticism, guilt | Long-term survivors had higher psychological distress and showed higher levels of anxiety ( |
| Marshall | Each patient was asked about the occurrence of traumatic events 5 years before the first recognition of symptoms (deaths, illnesses, divorces, unemployment). Also patients were asked questions about the extension of social involvement (marital status, participation in religious/non-religious groups). Only women whose deaths have been recorded were included in the study | All patients died. Mean of survival of women <46 years in lower and higher stress quartile: 75.8 months and 50.8 months, respectively. Mean of survival of women 45 to 60 years in lower and higher stress quartile: 54 months and 39.2 months, respectively. Mean of survival of women >61 years in lower and higher stress quartile: 53.4 months and 54.9 months, respectively | Stress (deaths, illnesses, divorces, unemployment), social involvement (marital status, relatives and acquaintances, organization memberships) | The single most powerful predictor of survival is stage. The only statistically significant indicator is social involvement only for the younger age group |
| Jensen | Assessment of repressive defensiveness with Marlowe-Crown Social Desirability Scale, Bendig Short Form of the Taylor Manifest Anxiety Scale. Assessment of convergent validity with Sackeim and Gur's Self Deception and Other Deception Questionnaires. Assessment of attention to inner experience using Absorption Scale of Tellegen's Differential Personal questionnaire and Huba, Aneshensel, Singer's Short Form of the Imaginal Processes Inventory. The participants in the study also completed the Millon Behavioral Health Inventory. All three groups were equated on variables reflecting known or suspected genetic, hormonal and socioeconomic factors. The groups with cancer were also compared with regard to factors present at diagnosis associated with the progress of the disease at follow-up | At follow-up (G1, 336 days on average for the 11 patients who died and 636 days on average for the rest; G2, 734 days on average) four women in G1 were in remission, four women in G2 developed recurrence. One died from brain tumour unrelated to breast cancer | Repressive defensiveness, helplessness, expression of negative affect, chronic stress, positive constructive daydreaming | All five psychological variables were significant by |
| Jamison | Filling of eight questionnaires: Situation Response Scale of general trait anxiousness, General Well Being Scale, Health Value Rating Questionnaire, Self Esteem Inventory, Hostility Scale of the Multiple Affect Adjective Checklist, Zung Depression Scale, Spielberg Trait Anxiety Inventory, Multidimensional Health Locus of Control Scale. Demographic data were acquired at testing and medical data from charts | By the time of analysis all the patients had died from their illness. The patients were divided into two groups: short-term survivors (X = 10.8 months) and long-term survivors (X = 30.4 months) | Anxiety, adjustment, self-esteem, hostility, depression, health locus of control | No consistent differences found between short- and long-term survivors on any psychosocial variable assessed |
| Hislop | Patients were asked to complete short self-administered questionnaires (90% completed within 3 months of diagnosis). Information was obtained about types of usual activities, extroversion, neuroticism, self-esteem, locus of control, recent life events, coping behavior, psychiatric symptoms (including anxiety, anger, depression, cognitive disturbance such as forgetfulness, difficulty concentrating and making decisions). Clinical data were obtained from medical records | 26 deaths (25 attributed to breast cancer) and 38 recurrences over the 4 years of follow-up | Types of usual activities, extroversion, neuroticism, self-esteem, locus of control, recent life events, coping behaviour, psychiatric symptoms (including anxiety, anger, depression, cognitive disturbance such as forgetfulness, difficulty concentrating and making decisions) | Involvement in expressive activities and low level of anger were associated with significantly better survival and disease-free survival. Extroversion was associated with significantly better survival. Low level of cognitive disturbance was associated with significantly longer disease free survival |
| Cassileth | Self-report questionnaire including items on seven factors; social ties and marital history, job satisfaction, use of psychotropic drugs, general life evaluation/satisfaction, subjective view of adult health, hopelessness/helplessness, (and one item found to predict survival in patients with cancer) perception of the amount of adjustment required to cope with a new diagnosis | Group II (only this group included breast cancer patients): the total sample of patients in this group was 158, since 3 patients were accrued to the study after the original analysis. Of that total, 7 (4.43%) died without recurrence of their malignancy, 1 (0.63%) was lost to follow-up and 1 (0.63%) developed a new primary breast cancer. Of the remaining 149 patients, 64 (43%) had documented recurrence of their disease, while 85 (57%) remained in remission | Social ties and marital history, job satisfaction, use of psychotropic drugs, general life evaluation/satisfaction, subjective view of adult health, hopelessness/helplessness, perception of the amount of adjustment required to cope with a new diagnosis | Group II: two psychosocial variables were significantly associated with time to recurrence. Those who scored in the middle third of the Hopelessness Scale had significantly lower risk of recurrence (RR = 0.52, 95% CI, 0.28 to 0.96; |
| Levy | Patients were assessed early in the course of hospitalization (before any treatment), reassessed 4 weeks later and at that time their physicians were asked to predict survival time. Patients were given a structured interview and filled out the Affect Balance Scale (ABS) | At the time of analysis 24 of 36 women had died of their disease. Average survival from date of recurrence was 2 years | ABS overall negative mood score, hostility score, overall positive mood score, joy score | Patients who expressed more joy in the baseline testing, who had longer disease-free survival, who were predicted by their physicians to live longer and had fewer metastatic sites had longer survival time ( |
| Ramirez | Adverse life events and life difficulties occurring during the postoperative disease free survival were recorded. Adverse life experiences were measured with Bedford College life events and difficulties schedule. Life events were rated as severe if they had threatening implications (that is, death of a husband or child). Difficulties that carried a pronounced threat and persisted at least 6 months were rated as severe (that is, taking care for a physically handicapped child) | The median interval free of disease for women who had a relapse was 30.5 months | Stressful events (severe, non severe) and difficulties (severe, non severe) | Relative risk for relapse: after severe events, 5.67 (1.57 to 37.20), |
| Barraclough | Three home interviews at 4, 24, and 42 months after operation yielded data about the period from 1 year before surgery until 3.5 years afterwards. The Bedford college life events and difficulties schedule was used to assess life events. Interviews were taped and discussed by the investigators | Relapse of breast cancer was confirmed in 47 (23%) of the 204 breast cancer cases; 26 of these had died by the end of the follow-up period (4 to 42 months after operation); 1 patient died from a reason unrelated to cancer | Life events, social difficulties, depressive symptomatology | For severe life events or social difficulties during the year before surgery, the hazard ratio was 0.43 (95% CI 0.20 to 0.93); during the follow-up period, the hazard ratio was 0.88 (0.48 to 1.64). For prolonged major depression before surgery and during follow up, the hazard ratios were 1.26 (0.49 to 3.26) and 0.85 (0.41 to 1.79). respectively. For absence of a full confidant before surgery, figures were 0.93 (0.42 to 2.09), and during the follow-up period figures were 0.86 (0.38 to 1.93) |
| Morris | Interview at 3 months post diagnosis, further tests at 6 to 9 months post diagnosis and another interview at 12 months. Follow up at 5 years post diagnosis. Tests used: Wakefield Self Assessment Depression Inventory, Spielberger State Trait Anxiety Inventory, Multidimensional Health Locus of Control Scale, Courtauld Emotional Control Scale | At 5 year follow up: 20 patients had died, 8 were alive with recurrence, 79 were alive without evidence of recurrence | Patient's Responses to Diagnosis (PRD): fighting spirit (PRD 1), denial (PRD 2), anxious preoccupation (PRD 3), stoic acceptance (PRD 4), helplessness/hopelessness (PRD 5) | PRD code was associated with poorer survival |
| Reynolds | Information about two dimensions of social ties: structural, which reflect marital status, group participation, contacts with friends and relatives (the questions were based on Beckman SNI); and functional, which reflect perceived emotional support (the questions were based on Seeman's study of angiography patients). 87% of interviews took place within 6 months of diagnosis. Follow up information was obtained from Surveillance, Epidemiology, End Results database and National Cancer Institute | Data of survival reported in NCI Black White Cancer Survival Study | Marital situation, church group participation, other group participation, friends/relatives, contacts, social network index, emotional support, instrumental support | Absence of close ties and perceived sources of support were associated with increased breast cancer death rate. White women with few friends had increased death rate (RR = 2.1, CI 1.1 to 4.4). Black and white women with few sources of emotional support had increased breast cancer death rate (RR = 1.8, CI 1.3 to 2.5) |
| Tross | Assessment of psychological symptoms prior to chemotherapy using the Symptoms Checklist-90 revised questionnaire. Scores where trichotomized and Global Severity Index was extracted. Sociodemographic (age, ethnicity, education, and so on) and medical data were also collected | Disease free survival for patients with low, medium, high GSI was: 7.48, 7.04 and 4.90 years, respectively. Overall survival for patients with low, medium, high GSI was: 11.62, 10.21 and 9.58 years, respectively | Somatization, obsessive-compulsive symptoms, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism | This study failed to provide evidence that psychological factors contributed to length of disease-free or overall survival of women who received adjuvant chemotherapy for treatment of stage II breast cancer |
| Buddeberg | An interview every 12 months (sociodemographic data, attitude toward cancer and quality of life data) and 2 coping questionnaires: Zurich questionnaire of Coping with Illness (ZQCI) and Freiburg Questionnaire of Coping with Illness (FQCI). The ZQCI was administered every 3 months in the 1st year (assessments 1 to 5) and every 6 months during the 2nd and 3rd year (assessments 6 to 9). FQCI every 12 months (assessments 1, 5, 7, 9). ZQCI and FQCI are self-reported measures with five-point answer-scales for each item | 5 to 6 years after the primary surgical treatment: 66.4% were recurrence-free and had no signs of cancer disease, 1.9% had a local-regional recurrence, 5.6% were afflicted with distant metastases, 23.4% had died from breast cancer, 1.9% developed a 2nd carcinoma, and 0.9% died from a cardiac disease | Coping strategies based on two questionnaires | There is no steady significant relationship between the different coping strategies and disease outcome |
| Kreitler | Filling of four questionnaires (background information, Psychosocial Adjustment to Illness Scale (PAIS), State-Trait Anxiety Inventory, Locus of control) by a mean of 13.34 months after surgery or 9.89 months after end of treatment. Medical parameters were also examined (stage of disease, estrogen/progesterone receptor status). The health state of patients was examined again 3 and 5 years after surgery | After 3 years: 73.96% were in a good state of health and 1.04% had died. After 5 years: 70.83% were in a good state of health and 14.58% had died | Adjustment, locus of control, anxiety | Both medical and psychological variables are significant predictors for good health state on 3 years and survival on 5 years. The most important psychological predictor was adjustment (especially with regard to sexual and social relations) |
| Tominaga | Examination of medical records and personal interviews with the patients at first admission | During the study period and up to October 1995, 48 (12%) patients died of breast cancer and 348 (87.4%) patients were alive | Marital status, having children, number of female and male children, participation in the meetings of patients, having a hobby, number of hobbies, religion, habit of smoking, and habit of drinking alcohol | Being a widow was significantly associated with decreased survival (hazard ratio 3.29, 95% CI 1.32 to 8.20, |
| Brabander and Gerits 1999 [20] | Chronic stress was measured with the Dutch version of the Hopkins Symptom Check List on the day of admission. Acute stress was measured with the Dutch version of the Depression Adjective Checklist, before and after the communication of the biopsy results. Natural killer activity (NKA) and the number of NK cells (before and after the biopsy results) were determined as indicators of the immunological consequences of acute stress, while measurement of 3-methoxy-4-hydroxy-phenyl-glycol (MHPG; before and after the biopsy results) was used as a neurochemical indicator of acute stress. Patients were also interviewed by means of audiotaped semi-structured interviews on their expectation about the result of the biopsy | After a follow-up period of 3.5 years, 10 (22.7%) patients had relapsed; 9 of the 10 relapsed patients (90%) had developed metastases and 1 patient (10%) had developed a new carcinoma in the other breast | Acute stress and chronic stress | Acute stress and chronic stress were a significant predictor of early relapse at 3.5 years of follow-up |
| Watson | Participants completed self-administered questionnaires at 4 to 12 weeks after diagnosis and 1 year later. Mental Adjustment to Cancer (MAC) scale, Courtauld emotional control (CEC) scale, and hospital anxiety and depression (HAD) scale | At 5 years, 395 (68.3%) women were alive and without relapse, 50 (8.65%) were alive with relapse, and 133 (23%) had died (122 (21.1%) of breast cancer) | Patients' reactions to having cancer (fighting spirit, helplessness or hopelessness, anxious preoccupation, fatalism, and avoidance). The extent to which patients suppress negative emotions (anger, anxiety, sadness), and presence of depression or anxiety | Psychological assessment at baseline: women with a high score on the HAD scale category of depression had a significantly increased risk of death from all causes by 5 years (hazard ratio 3.59, 95% CI 1.39 to 9.24). Women with high scores on the helplessness and hopelessness category of the MAC scale had a significantly increased risk of relapse or death at 5 years, compared with women with a low score in this category (hazard ratio 1.55, 95% CI 1.07 to 2.25). Fighting spirit was not associated with disease outcomes. Psychological assessment at 1 year follow-up: the increased risk of death during follow up for the HAD scale category of depression remained significant (adjusted hazard ratio 4.04, 95% CI 1.54 to 10.64) for a score of >11 on HAD scale depression. The effect of MAC helplessness or hopelessness on event-free survival was reduced from baseline (hazard ratio 1.35, 95% CI 0.91 to 200) and was no longer significant |
| Reynolds | Patients were followed for survival through 1994 (since 1985 to 1986). They were administered a modified Folkman and Lazarous Ways of Coping Questionnaire. Coping strategies were characterized via factor analysis of the responses. Interviews took place within 3 months of diagnosis. Follow-up information was obtained from Surveillance, Epidemiology, End Results database and National Cancer Institute | 218 deaths due to breast cancer (137 black women, 81 white). Median follow up for women who had not died: 107 months | Seven coping strategies; expressing emotions, wishful thinking, problem solving, positive reappraisal, avoidance, escapism | Expression of emotions was associated with better survival (hazard ratio 0.6, 95% CI 0.4 to 0.9). Women who reported both low expression of emotions and low perceived emotional support had shorter survival (hazard ratio 2.5, 95% CI 1.7 to 3.7) |
| Butow | Patients answered a series of questionnaires, repeated every 3 months for up to 2 years following study entry. In this paper there is only the analysis of the initial questionnaire of each patient. Self-report adaptation of the Weisman and Wordon General Coping Strategies Scale (COPE), Psychological Adjustment to Cancer scale (PAC), Multidimensional Support Scale (MDSS), Quality of Life measured by GLQ-8 LASA scales, and patients' perceptions of the aim of the treatment at the initial assessment only (four options: complete cure, increased long-term survival, increased short-term survival, or reduction of symptoms) | Survival was measured from date of study entry to date of death or censored at the date of last follow up for surviving patients; 63% died within the study period | Coping strategy, psychological adjustment, social support, quality of life, and perceptions regarding the aim of treatment | The adjustment style of minimization (minimizing the impact of cancer on social, work, and family life) was significantly associated with survival. Patients who minimized the impact of cancer survived longer (median of 29 versus 23.9 months after study entry (hazard ratio 0.932, CI 0.883 to 0.984, |
| Weihs | The collection and interpretation of data regarding psychological assessments begun at least 6 months after recurrence and prior to the known terminal phase (that is after the acute adjustment to breast cancer recurrence and before the effects of terminal illness). Patients completed questionnaires; negative affectivity/mood was measured with the Profile of Mood States and the Taylor Manifest Anxiety Scale (MAS). Restriction of emotions was measured with the Control of Feelings Scale and the Marlowe Crowne (MC) Social Desirability Scale. Chronic anxiety and emotional constraint scores were used to create four emotion regulatory style groups: low anxiety/low emotional constraint, low anxiety/high emotional constraint, high anxiety/low emotional constraint, and high anxiety/high emotional constraint | At end of data collection, 19 of 32 patients had died. Median time from first occurrence to death or last observation was 2.5 years (range 0.9 to 4.4 years). Median survival time after study enrolment to death of last observation was 1.7 years (range 02 to 3.2 years) | Negative affectivity, negative mood states, and restriction of emotions | Bivariable analysis: low chronic anxiety in the context of low emotional constraint predicted low mortality (RR = 0.07, CI 0.009 to 0.52, |
| Graham | Collected data on stressful experiences and depression, interviews (tape recorded and transcribed) carried out every 18 months and covered the period from 12 months before diagnosis to 5 years after diagnosis. Final interview with patients who had a recurrence took place approximately 8 weeks after diagnosis. Collected data on stressful life experiences by using the Bedford College life events and difficulties schedule. At each interview elicited psychiatric symptoms using the structured clinical interview with criteria from the DSM III R | Recurrence of disease was confirmed in 54 (31.6%) women. The overall five year relapse-free survival was 76% (95% confidence interval 68.6 to 81.1) Some patients died soon after recurrence, and four, out of the final interviews, were completed by the woman's closest relative | Discrete life events and longstanding difficulties (for example, divorce, caring for a severely handicapped child) | No evidence that women who have a severely stressful life experience in the year before breast cancer diagnosis, or in the 5 years following are at any increased risk of developing a recurrence of their disease. An episode of depression before diagnosis did not increase the risk of recurrence (hazard ratio 1.22, CI 0.38 to 3.92, |
| Soler-Vila | 42% of the patients were interviewed within 3 months, 90% within 6 months of the date of diagnosis. Participants were interviewed in their homes with the use of a modified version of the questionnaire used in the National Cancer Institute Black/White Cancer Survival Study; this instrument collected information on sociodemographic, health history, medical care, and psychosocial factors | Survival was defined as time from breast cancer diagnosis until death or censoring by last contact date. During the study period there were 135 (41.9%) deaths from any cause and 99 (30.7%) deaths from breast cancer | Coping styles (denial, passive coping, and isolation), perceived emotional support, fatalism, and health locus of control | Lower perceived emotional support at diagnosis was associated with a higher risk of death from any cause (hazard ratio 1.39, 95% CI 1.09 to 1.79, |
| Soler-Vila | 42% of the patients were interviewed within 3 months, 90% within 6 months and the remaining 10% within 1 year of the date of the diagnosis. Interviews were based on a modified version of the questionnaire used in the National Cancer Institute Black/White Cancer Survival Study, which gathered information on sociodemographics, health history, medical care, and psychological factors | Survival was defined as time from breast cancer diagnosis until death or censoring by last contact date. By the end of the study period (2002), there were 160 deaths from any cause (49.7%), out of which 105 were due to breast cancer (65.6%), 55 due to diseases of the circulatory system (13%) and 13 due to other neoplasms (8%) | Beliefs about cancer detection, treatment, and curability of cancer disease | Perceived cancer incurability was associated with a higher risk of death from any cause (all-cause mortality; hazard ratio 1.67, 95% CI 1.11 to 2.51), though not associated with breast-cancer mortality |
| Hjerl | Information about depression was obtained from the Danish Psychiatric case register, which provides information for admissions to all psychiatric departments and hospitals in Denmark. Records of the patients were obtained from Danish Breast Cancer Cooperation Group. Information about death obtained from Mortality Danish National Register of causes of death | During the study period (1977 to 1993) 5,648 patients (27.4%) died from natural causes and 79 patients (0.4%) died from unnatural causes | Depression defined as all affective and anxiety disorders divided and categorized into five ordinal groups (bipolar, unipolar, reactive disorder, dysthymia, anxiety). Preoperative depression was defined as any psychiatric admission with any of the above mentioned ordinal groups at >15 years of age, from April 1969 to December 1993, at least 3 months before breast cancer diagnosis | Preoperative depression was associated with significantly higher relative risk of mortality for late stage breast cancer. The same trend but non-significant was seen in the early stage breast cancer group. The most pronounced effect was noticed in patients with bipolar diagnosis (compared with the other diagnosis) |
| Goodwin | Completion of health-related quality of life (HRQOL) and psychosocial questionnaires shortly after breast cancer diagnosis and 1 year later (sent and returned by mail). European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30), Profile of Mood States (PMOS) questionnaire, Impact of Events Scale (IES), Mental Adjustment to Cancer Scale (MAC), Courtauld Emotional Control Scale (SECS), Psychosocial Adjustment to Illness Scale Self-Report (PAIS-SR). Women were followed through an ongoing review of medical records | 50% of the patients were followed ≥6 years, 3 (0.75%) women were followed up for less than 1 year, 55 (13.85%) experienced distant recurrences, and 34 (8.56%) women died of breast cancer; 2 (0.5%) women experienced non-breast cancer-related deaths | Health-related quality of life, mood state, stress response syndrome, coping strategies, emotional control, psychological adjustment to illness | No consistency of associations across outcomes or questionnaires between health-related quality of life and psychosocial status and breast cancer prognosis. There was little evidence of significant prognostic associations of 1 year psychosocial measurements. Out of 140 investigated prognostic associations, only 4 were statistically significant: role functioning (EORTC QLQ-C30) was significantly associated with overall survival (OS; |
| Osborne | Hospital Anxiety and Depression Scale (HADS), Duke-UNC Functional Social Support (DUFS), Mental Adjustment to Cancer (MAC). Approximately two-thirds of the patients were interviewed between 5 and 9 months following diagnosis, the remaining one-third was interviewed 9 to 17 months following diagnosis | Minimum time from interview to follow-up was 6.1 years and maximum 7.9 years. Survival was measured from date of interview to date of death from breast cancer, or was censored at the date of last follow-up or date of death from other causes; 18 (29%) patients had died, 14 (23%) from breast cancer, 3 (4.8%) from other causes, and in 1 case the cause of death could not be verified; 5 years after diagnosis there were 11 deaths (18%) | Anxiety, depression, mental adjustment to cancer and social support | Fighting-spirit minimizing the illness; high score in MAC subscale was associated with longer survival (HR 0.77, |
| Weihs | The number of dependable support persons and the amount of contact with them were assessed within 18 months after diagnosis in women with stage II or III breast cancer. At the time of enrolment (1991 to 1993) patients were assessed for support and disease severity (with the use of the Nottingham Prognostic Index (NPI)) and then monitored for disease status through December 2000. Participants listed the first names of supportive relatives and friends and gave the frequency of contact with each person. To estimate the disease outcome, participants' medical charts were reviewed annually. Treatment aggressiveness was also assessed | Time to recurrence or death was set at the date of enrolment to the study (1991 to 1993) until December 2000. At the end of the study period there were 16 (17.7%) deaths from breast cancer and 21 (23.3%) recurrences, while 3 (3.33%) participants died from other causes | Social support: the number of supportive relatives and friends and the frequency of contact with each one | Survival analyses using the number of dependable supports and NPI (disease severity) as simultaneous predictors showed decreased mortality in participants with a 1 standard deviation increase in dependable supports (SD = four dependable supports): (RR = 0.41, CI 0.21 to 0.80, |
| Osborne | Data were from the Surveillance, Epidemiology and End Results (SEER) tumour registries, merged with Medicare data for the years 1991 through 1995. From the SEER program, information regarding tumour location, size, axillary node status, American Joint Committee on Cancer Stage (AJCC), estrogen receptor status, demographic characteristics (age, sex, race, and marital status), and types of treatment provided within 4 months after the date of diagnosis was obtained. The data from the Medicare program used in the study were the Medicare Provider Analysis Review File, the Hospital Outpatient Standard Analytic file, and the 100% physician/supplier file. Information available through 1998 allowed for 3 years follow-up | Marital status | Unmarried women were at an increased risk of death from breast cancer (hazards ratio 1.25, 95% CI 1.14 to 1.37) | |
| Lehto | Interviews of the patients based on the Ways of Coping questionnaire (WOC), the MOS Social Support Survey, the Anger Expression Scale (AX/Scale), Life Experience Survey (LES), the Rotterdam Symptom Checklist (RSCL), and the Depression Scale (DEPS) | Survival was measured from the day of diagnosis to the day of advancement of the disease (event-free survival) or date of death (overall survival) or day of the last follow-up (15 February 2005). At 15 February 31 patients had relapsed (30.7%) and 20 (19.8%) had died | Coping strategies, emotional expression, anger expression, perceived available social support, non-cancer life stresses, and quality of life 3 to 4 months after diagnosis | In univariate analysis: emotional defensiveness ( |
| Kroenke | Social networks were assessed in 1992, 1996, and 2000 with the Berkman-Syme Social Networks Index (SNI). Social support was assessed in 1992 and 2000 as the presence and availability of confidant. Social-emotional support was assessed in 1992 and 2000 as the presence and availability of a confidant | 224 deaths (107 of these related to breast cancer) accrued to the year 2004 | Social-emotional support (presence and availability of a confidant and the frequency of communication with him/her) and social networks (marital status, church group membership, membership in other community organizations) | Prediagnostic analyses of social networks and survival: women who were socially isolated before diagnosis had a subsequent 66% increased risk of all-cause mortality (hazards ratio (HR) = 1.66; 95% CI 1.04 to 2.65) and a two-fold increased risk of breast cancer mortality (HR = 2.14, 95% CI 1.11 to 4.12) compared with those who were socially integrated. The presence and extent of contact with a confidant was associated with survival. Women without close relatives (HR = 2.65, 95% CI 1.03 to 6.82), friends (HR = 4.06, 95% CI 1.40 to 11.75), or living children (HR = 5.62, 95% CI 1.20 to 26.46) had increased risk of breast cancer mortality and of all-cause mortality (HR = 1.66, 95% CI 0.93 to 2.97; HR = 2.20, 95% CI 1.01 to 4.81; and HR = 4.03, 95% CI 1.65 to 9.86, respectively) after diagnosis, compared with those who were socially integrated. Participation in religious or community activities, having a confidant and being married were not associated with survival. Postdiagnostic analyses of social networks and survival: lower social networks, following diagnosis, were not significantly associated with survival. Participation in group activities postdiagnosis appeared to predict a slightly lower risk of mortality (HR = 0.70, 95% CI, 0.44 to 1.11). The presence and extent of contact with a confidant was not associated with survival |
Characteristics of studies examining the effect of psychological intervention on breast cancer survival
| Reference | Setting | Type of study | Study population | Aim of the study |
| Spiegel | California, USA | Prospective | 86 women with metastatic carcinoma of the breast. Intervention group: 50 patients. Control group: 36 patients | Examination of the effect of psychosocial intervention on survival of patients with metastatic breast cancer |
| Gellert | New Haven, Connecticut, USA | Retrospective cohort study | 102 non-participants and 34 participants in the psychological support program were matched on major prognostic factors. Both groups were monitored from the day of cancer diagnosis (1971 through 1980) until March 1991 | Examination of the effect of a psychosocial intervention on breast cancer survival |
| Cunningham | Princess Margaret Hospital, Toronto, Canada | Prospective case control study | Intervention group: 30 patients with metastatic breast cancer. Control group: 36 patients with metastatic breast cancer | Examination of the effect of a psychological intervention on breast cancer survival |
| Edelman | Australia | Prospective case control study | 121 patients with metastatic breast cancer, of whom 60 participated in the cognitive behavioural therapy program (therapy group) and 61 did not (control group | Examination of the effect of a psychological intervention on breast cancer survival |
| Shrock | Two rural hospitals or cancer centres in Pennsylvania | Matched case control | Intervention group: 21 patients with stage I breast cancer. Control group: 74 patients with stage I breast cancer | Examination of the effect of a psychological intervention on breast cancer survival |
| Goodwin | Samuel Lunenfeld Research Institute at Mount Sinai Hospital, University of Toronto. Also participated: Hamilton Regional Cancer Center, Hamilton, Ontario; Ottawa Regional Cancer Center, Ottawa Ontario; Cancer Care, Manitoba, Winnipeg; Tom Baker Cancer Center, Calgary, Alberta; British Columbia Cancer Agency, Vancouver; Cross Cancer Institute, Edmonton, Alberta | Prospective | 235 women with metastatic breast cancer, expected to survive at least 3 months (intervention group, 158 women; control group, 77 women) | Examination of the effect of a psychological intervention on breast cancer survival |
Methods and outcomes of studies examining the effect of psychological intervention on breast cancer survival
| Reference | Method | Disease outcome | Psychological/psychosocial factors examined | Main findings |
| Spiegel | Patients were randomly assigned to the intervention or the control group, by a mean of 24.4 months from first metastasis (intervention group) and 21.9 months from first metastasis (control group). The 1 year intervention consisted of weekly supportive group therapy, led by a psychiatrist or social worker with a therapist who had breast cancer in remission. Groups were encouraged to discuss how to cope with cancer, express their feelings, be more assertive with doctors. They were not led to believe that they would live longer. Self hypnosis was taught for pain control | At 10 years follow up only 3 patients were alive. Survival for the intervention group was a mean of 36.6 months and for the control group survival was a mean of 18.9 months | Participation in a psychosocial support therapy program | Patients in the intervention group lived significantly longer ( |
| Gellert | Support program (Exceptional Cancer Patients (EcaP)) consisted of weekly cancer peer support and family therapy, individual counselling, and use of positive mental imagery, meditation, and relaxation. Using data from local hospital tumour registries in 1981, three women with breast cancer were matched to each EcaP participant regarding age at histological diagnosis, race, stage of disease, surgery, and sequence of malignancy. Subjects retrospectively monitored for survival time through March 1991, using records from the State of Connecticut Tumor Registry. Two analyses were made, an unadjusted and a restricted one. In the latter, non-participants were restricted to those who had a survival time greater than that of the matched case at time of entry into the support program | Unadjusted analysis: 41% of EcaP participants survived 10 years, compared with 47% of non-participants. Restricted analysis: 37% of non-participants survived 10 years | Participation in a psychosocial support therapy program | There was no significant association between psychosocial intervention and breast cancer survival |
| Cunningham | The intervention group was offered 35 2-hour weekly sessions of supportive and cognitive behavioural therapy. Patients in the intervention group were also given 20 cognitive behavioural assignments as homework and were encouraged to attend a weekend training in coping skills, especially relaxation, stress management, thought monitoring, goal setting and mental imaging. The control group received only a home study cognitive behavioural package | At 5 years follow up median survival on the intervention group was 28.2 months. Median survival on the control group was 23.6 months (probably due to the longer medial interval between metastatic diagnosis and entering the study in the control group) | Participation in supportive plus cognitive behavioural therapy groups | There was no significant association between psychosocial intervention and breast cancer survival |
| Edelman | Initially, 124 patients were recruited for the study, of whom 62 were randomly allocated to the intervention group and received cognitive behaviour therapy, whereas 62 were allocated to a standard care control group. Three patients (two from the therapy group and one from the control group) were excluded because they did not have metastatic disease. Patients were recruited between March 1994 and February 1997; thus, at the time of survival analysis participants had entered the study between 2 and 5 years previously. Of these patients, 38 had been identified through the medical records of the Royal North Shore Hospital, Sydney; doctors at other hospitals referred 3 and 83 responded to media publicity. Demographic information from patients, medical information from hospital records. Treating physicians completed Eastern Cooperative Oncology Group (ECOG) Performance status and Disease Status forms at each assessment period. Two self-report instruments for information on psychological criteria: the Profile of Mood States and the Coopersmith Self-esteem Inventory. Assessments were conducted prior to intervention, following intervention, and at 3 and 6 months after intervention. | Survival time was calculated from the day of entry to the study. At the time of survival analysis, 85 (70.2%) patients had died | Participation in a group cognitive behavioural therapy program | There was no significant association between psychosocial intervention and breast cancer survival |
| Shrock | Six two-hour psychology classes. Class topics: beliefs/feelings/attitudes toward health, relaxation/imagery techniques, nutrition, exercise, stress management, self-esteem, spirituality, receptive imagery/intuition, problem solving and personal health plan setting. The 21 breast cancer patients who received intervention were matched with 74 breast cancer patients of the same stage. There were two to three matched controls for each patient | At 4 to 7 years follow up none of the intervention group had died, 12% of the control group had died (median follow-up 4.2 years) | Participation in health psychology classes | The intervention control group lived significantly longer ( |
| Goodwin | Women participating in the intervention group attended weekly meetings lasting 90 minutes. Therapy intended to foster support among members and encourage the expression of emotions about cancer and its effects on their lives. Patients were encouraged to attend sessions for at least 1 year. The primary outcome was survival and the secondary psychosocial function assessed by self-report questionnaires (Profile of Mood States and Pain Suffering Scales by Spiegel-Bloom) at baseline and at 4, 8 and 12 months | By the time of analysis 201 patients had died. The median survival for the intervention group was 17.9 months, and for the control group was 17.6 months | Participation in supportive-expressive group therapy | There was no significant association between psychosocial intervention and breast cancer survival |
Association of the examined psychosocial factors with survival/recurrence
| Survival | Recurrence | No impact | |
| Coping | [9], [17], [23], [26] | ||
| Cognitive/role functioning | + [29] | + [29]a | |
| Beliefs about cancer incurability | [27] | ||
| Fighting spirit | + [30] | -[4] | [14], [21], [29] |
| Stressful events | -[29] | + [12], -[13], -[25]b | [6], [9], [13]c, [25] |
| Anxiety | -[7] | + [20] | [4], [5], [8], [9], [14], [16], [21], [29], [30] |
| Hopelessness/helplessness | -[7] | + [4], + [10], + [21] | [14], [21]d, [29], [30] |
| Joy | + [11] | [5] | |
| Depression/negative mood | + [5], -[11], -[21], -[24], -[28], -[33] | [4], [8], [9], [13], [16], [25], [30], [29], [33]e | |
| Perceived social support | + [15], + [26], -[33] | [30], [33]f | |
| Social support | + [6]g, + [15]h, + [31], + [34] | [4], [10], [13], [23], [30], [34]i | |
| Minimizing | + [23], + [33] | ||
| Repressive defensiveness/emotional constraints | -[7], -[24], -[33] | [4], [21], [33]j | |
| Adjustment | + [18]k | [4], [8] | |
| Fatalism/stoic acceptance | + [4] | [14], [21], [26], [29], [30] | |
| Positive constructing daydreaming | -[7] | ||
| Denial/avoidance | + [29], -[33] | -[4] | [14], [21] |
| Locus of control | [8], [9], [18], [26], [30] | ||
| Anger/hostility | + [5], -[9], -[11] | + [9] | [4], [8], [16], [29] |
| Vigor/activity | [5], [29] | ||
| Fatigue/inertia | [29] | ||
| Guilt | + [5] | ||
| Extroversion | + [9] | [4] | |
| Expressive activities | + [9] | -[9] | |
| Group participation (religious/non-religious) | + [6] | [15], [19], [34] | |
| Confusion/bewilderment | [29] | ||
| Somatization, obsessive-compulsive symptoms, interpersonal sensitivity, paranoid ideation, psychoticism | + [5] | [4], [9], [16] | |
| Self-esteem | [8], [9] | ||
| Hobbies | + [19] | ||
| Female child | + [19] | ||
| Marriage | + [6], + [19], + [32] | [10], [15], [29], [34] |
The number in brackets is the number of the reference. Symbols: +, increased survival/recurrence; -, decreased survival/recurrence. aCognitive functioning. bPost-diagnosis. cDuring follow-up period. dAt 1 year follow up. eRecurrence. fNo impact on recurrence. gYounger age groups. hWhite women. iPost-diagnosis. jRecurrence. kSexual adjustment. Minimisation: elimination of the impact of cancer on social, work, and family life. Perceived emotional support: reflects participant's ability to talk about disease related distresses with family/friends. Locus of control: reflects patient's beliefs about whether health outcomes are under control of powerful others/random forces. Emotional defensiveness: suppression and control of emotions.